News

Pharmabiz7m
Signify & SELCO Foundation team-up to solarize 10 24x7 primary health centres in Karnataka under the ‘Swasthya Kiran’ CSR initiative
Signify & SELCO Foundation team-up to solarize 10 24x7 primary health centres in Karnataka under the ‘Swasthya Kiran’ CSR initiative: Our Bureau, Bengaluru Wednesday, April 30 ...
Pharmabiz21m
UK MHRA grants marketing approval for BridgeBio Pharma’s Beyonttra to treat ATTR-CM
UK MHRA grants marketing approval for BridgeBio Pharma’s Beyonttra to treat ATTR-CM: Palo Alto, California Wednesday, April 30, 2025, 16:00 Hrs [IST] BridgeBio Pharma, Inc., a n ...
Pharmabiz37m
AI will revolutionize industry practices and create new business models: ‘KPMG global tech report: Life sciences insights’
Life sciences leads all industries surveyed in prioritizing and investing in edge and quantum computing, VR/AR/XR, spatial computing, XaaS technology and modern delivery. Globally, the life sciences ...
Pharmabiz52m
ASPA moots forming action group to strengthen presence in MEA
ASPA moots forming action group to strengthen presence in MEA: Our Bureau, New Delhi Wednesday, April 30, 2025, 15:30 Hrs ...
Pharmabiz1h
Surgery care platform HexaHealth closes $12 million Series A fund raising
Surgery care platform HexaHealth closes $12 million Series A fund raising: Our Bureau, New Delhi Wednesday, April 30, 2025, 15:15 Hrs [IST] HexaHealth, a leading tech-enabled surg ...
Pharmabiz1h
AbbVie receives US FDA approval for Rinvoq for treatment of adults with giant cell arteritis
AbbVie announced the US Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA). This comes after the ...
Pharmabiz2h
Boehringer’s new zongertinib data demonstrates durable and clinically meaningful results in patients with HER2 (ERBB2)-mutant advanced NSCLC
Ingelheim, Germany Wednesday, April 30, 2025, 14:00 Hrs [IST] ...
Pharmabiz2h
Spectra Medical introduces EndoliftX, a microfiber based non-surgical aesthetic treatment in India
Spectra Medical introduces EndoliftX, a microfiber based non-surgical aesthetic treatment in India: Our Bureau, Mumbai ...
Pharmabiz3h
EMA committee recommends approval of AstraZeneca’s fixed-duration Calquence-based regimens for 1st-line chronic lymphocytic leukaemia
EMA committee recommends approval of AstraZeneca’s fixed-duration Calquence-based regimens for 1st-line chronic lymphocytic leukaemia: Cambridge, UK Wednesday, April 30, 2025, 1 ...
Pharmabiz4h
Bayer begins phase I study targeting GPC3 with actinium-225 radiopharmaceutical in patients with advanced hepatocellular carcinoma
Bayer begins phase I study targeting GPC3 with actinium-225 radiopharmaceutical in patients with advanced hepatocellular carcinoma: Berlin Wednesday, April 30, 2025, 12:00 Hrs [IS ...
Pharmabiz5h
US FDA grants breakthrough device designation to Roche’s companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer
US FDA grants breakthrough device designation to Roche’s companion diagnostic, VENTANA TROP2 (EPR20043) RxDx Device for non-small cell lung cancer: Basel Wednesday, April 30, 20 ...
Pharmabiz6h
AstraZeneca to discontinue CAPItello-280 phase III trial of Truqap in metastatic castration-resistant prostate cancer
AstraZeneca to discontinue CAPItello-280 phase III trial of Truqap in metastatic castration-resistant prostate cancer: Cambridge, UK Wednesday, April 30, 2025, 10:00 Hrs [IST] Ast ...